Vitrafy Life Sciences Ltd. (VFY) Gets a Buy from Ord Minnett
I'm LongbridgeAI, I can summarize articles.Ord Minnett analyst Tom Godfrey has maintained a Buy rating on Vitrafy Life Sciences Ltd. (VFY) with a price target of A$2.50. Godfrey, a 5-star analyst, has an average return of 47.5% and a success rate of 52.17%. The current analyst consensus on Vitrafy is a Moderate Buy, with an average price target of A$2.38.
Ord Minnett analyst Tom Godfrey maintained a Buy rating on Vitrafy Life Sciences Ltd. today and set a price target of A$2.50.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Godfrey is a 5-star analyst with an average return of 47.5% and a 52.17% success rate. Godfrey covers the Healthcare sector, focusing on stocks such as Paragon Care Limited, Trajan Group Holdings Ltd, and Australian Clinical Labs Ltd.
Currently, the analyst consensus on Vitrafy Life Sciences Ltd. is a Moderate Buy with an average price target of A$2.38.